[144] Commault Systems, Inc. SEC Filing
Form 144 notice for Commvault Systems, Inc. (CVLT): The filer reports a proposed sale of 14,909 common shares through Morgan Stanley Smith Barney on 09/09/2025 on NASDAQ, with an aggregate market value of $2,716,729.91. These shares were acquired on 08/15/2025 from the issuer as 4,744 performance shares and 10,165 restricted stock. The filing also discloses a recent sale by Jennifer Dirico of 11,151 common shares on 08/18/2025 for gross proceeds of $1,985,264.94. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
- Clear disclosure of planned sale details: shares, broker, date, and market value
- Acquisitions identified as performance shares and restricted stock with specific unit counts
- Recent insider sales are sizable: 11,151 shares sold on 08/18/2025 for $1,985,264.94
- Planned sale market value is material at $2,716,729.91, which may raise investor questions about insider liquidity
Insights
TL;DR: Routine insider filing disclosing planned sale of newly issued shares and a recent sizable disposition; likely neutral to modestly negative for optics.
This Form 144 documents a planned sale of 14,909 shares (market value $2.72M) acquired on 08/15/2025 as compensation (performance and restricted stock). The filing gives investors visibility into insider liquidity and recent insider activity, including a prior sale of 11,151 shares for $1.99M on 08/18/2025. From a market-impact perspective, disclosure is timely and complete for a Rule 144 transaction; however, two relatively large insider dispositions in short succession may draw investor attention. There is no earnings or operational data in the filing to change valuation models.
TL;DR: Governance disclosure appears compliant; transactions are identified as issuer-granted equity being sold under Rule 144.
The filing indicates shares were granted by the issuer on 08/15/2025 and are being sold under Rule 144 through a broker-dealer, which aligns with standard post-vesting disposition processes. The representation concerning absence of undisclosed material information is present. There is no indication of a 10b5-1 plan date or other restrictive note in the remarks, so oversight of timing and insider trading policies may be relevant for governance review. No regulatory or litigation concerns are disclosed.